Pinsent Masons announces 2013-14 financial results

08 Jul 2014 | 09:00 am |

International law firm Pinsent Masons today announced preliminary unaudited financial results for the 2013-14 financial year.

Profit per equity partner (PEP) increased by 4.5% up to £405,000 from £387,000 last year while turnover saw a 4.6% rise to £323 million compared to £309 million in 2012-13.

Managing partner at Pinsent Masons, David Ryan, attributed growth in part to strong performances in banking and finance, real estate and projects, most notable in the Energy sector. The firm's international network performed well with Germany and the Middle East making a significant contribution.

Commenting on the results, David Ryan, said: “We’re pleased to have seen another year of good revenue growth. The extended period of investment we’ve made in the firm through merger, office openings and continued lateral hiring for our long-term benefit has put the firm in a strong position to capitalise on opportunity in the marketplace and our focus now is on realising the strongest returns and boosting profitability with a more modest level of investment continuing alongside."

"Our new finance director Charlotte Beckett joins in the Autumn and one of her early priorities will be to help us to ensure we are well positioned to drive up profitability following such a period of sustained growth.”

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts